Corrigendum to: "The Influence of Baseline Parameters on Changes in IPSS with Dutasteride, Tamsulosin, and Combination Therapy: Two-Year Data from the Combination of Avodart® and Tamsulosin (CombAT) Study" [Eur Urol Suppl 2008;7:171 (Abstract no. 403)] (DOI:10.1016/S1569-9056(08)60399-1)

Claus Roehrborn; Andrea Tubaro; Francesco Montorsi; Massimo Maffezzini; Thierry Lebret; Venancio Chantada; Jack Barkin; Ramiro Castro; Tim Wilson

doi:10.1016/j.eururo.2008.06.035

Corrigendum to: "The Influence of Baseline Parameters on Changes in IPSS with Dutasteride, Tamsulosin, and Combination Therapy: Two-Year Data from the Combination of Avodart^® and Tamsulosin (CombAT) Study" [Eur Urol Suppl 2008;7:171 (Abstract no. 403)] (DOI:10.1016/S1569-9056(08)60399-1)

Claus Roehrborn, Andrea Tubaro, Francesco Montorsi, Massimo Maffezzini, Thierry Lebret, Venancio Chantada, Jack Barkin, Ramiro Castro, Tim Wilson

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	1000-1001
Number of pages	2
Journal	European urology
Volume	55
Issue number	4
DOIs	https://doi.org/10.1016/j.eururo.2008.06.035
State	Published - Apr 2009

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.eururo.2008.06.035

Cite this

Roehrborn, C., Tubaro, A., Montorsi, F., Maffezzini, M., Lebret, T., Chantada, V., Barkin, J., Castro, R., & Wilson, T. (2009). Corrigendum to: "The Influence of Baseline Parameters on Changes in IPSS with Dutasteride, Tamsulosin, and Combination Therapy: Two-Year Data from the Combination of Avodart^® and Tamsulosin (CombAT) Study" [Eur Urol Suppl 2008;7:171 (Abstract no. 403)] (DOI:10.1016/S1569-9056(08)60399-1). European urology, 55(4), 1000-1001. https://doi.org/10.1016/j.eururo.2008.06.035

Corrigendum to: "The Influence of Baseline Parameters on Changes in IPSS with Dutasteride, Tamsulosin, and Combination Therapy: Two-Year Data from the Combination of Avodart^® and Tamsulosin (CombAT) Study" [Eur Urol Suppl 2008;7:171 (Abstract no. 403)] (DOI:10.1016/S1569-9056(08)60399-1). / Roehrborn, Claus; Tubaro, Andrea; Montorsi, Francesco et al.
In: European urology, Vol. 55, No. 4, 04.2009, p. 1000-1001.

Research output: Contribution to journal › Comment/debate › peer-review

Roehrborn, C, Tubaro, A, Montorsi, F, Maffezzini, M, Lebret, T, Chantada, V, Barkin, J, Castro, R & Wilson, T 2009, 'Corrigendum to: "The Influence of Baseline Parameters on Changes in IPSS with Dutasteride, Tamsulosin, and Combination Therapy: Two-Year Data from the Combination of Avodart^® and Tamsulosin (CombAT) Study" [Eur Urol Suppl 2008;7:171 (Abstract no. 403)] (DOI:10.1016/S1569-9056(08)60399-1)', European urology, vol. 55, no. 4, pp. 1000-1001. https://doi.org/10.1016/j.eururo.2008.06.035

Roehrborn C, Tubaro A, Montorsi F, Maffezzini M, Lebret T, Chantada V et al. Corrigendum to: "The Influence of Baseline Parameters on Changes in IPSS with Dutasteride, Tamsulosin, and Combination Therapy: Two-Year Data from the Combination of Avodart^® and Tamsulosin (CombAT) Study" [Eur Urol Suppl 2008;7:171 (Abstract no. 403)] (DOI:10.1016/S1569-9056(08)60399-1). European urology. 2009 Apr;55(4):1000-1001. doi: 10.1016/j.eururo.2008.06.035

Roehrborn, Claus ; Tubaro, Andrea ; Montorsi, Francesco et al. / Corrigendum to : "The Influence of Baseline Parameters on Changes in IPSS with Dutasteride, Tamsulosin, and Combination Therapy: Two-Year Data from the Combination of Avodart^® and Tamsulosin (CombAT) Study" [Eur Urol Suppl 2008;7:171 (Abstract no. 403)] (DOI:10.1016/S1569-9056(08)60399-1). In: European urology. 2009 ; Vol. 55, No. 4. pp. 1000-1001.

@article{ba47a57e9dc14366876d363c3ef8116e,

title = "Corrigendum to: {"}The Influence of Baseline Parameters on Changes in IPSS with Dutasteride, Tamsulosin, and Combination Therapy: Two-Year Data from the Combination of Avodart{\textregistered} and Tamsulosin (CombAT) Study{"} [Eur Urol Suppl 2008;7:171 (Abstract no. 403)] (DOI:10.1016/S1569-9056(08)60399-1)",

author = "Claus Roehrborn and Andrea Tubaro and Francesco Montorsi and Massimo Maffezzini and Thierry Lebret and Venancio Chantada and Jack Barkin and Ramiro Castro and Tim Wilson",

note = "Funding Information: {\textregistered} and Tamsulosin (CombAT) Study” [Eur Urol Suppl 2008;7:171 (Abstract no. 403)] Claus G. Roehrborn a ⁎ claus.roehrborn@utsouthwestern.edu Andrea Tubaro b Francesco Montorsi c Massimo Maffezzini d Thierry Lebret e Venancio Chantada f Jack Barkin g Ramiro Castro h Tim Wilson i a Department of Urology, UT Southwestern Medical Center, Dallas, Texas, USA b 2nd School of Medicine, La Sapienza University, Rome, Italy c Department of Urology, Universita Vita Salute San Raffaele, Milan, Italy d Department of Urology, Galliera Hospital, Genova, Italy e CMC Foch, Service d{\textquoteright}Urologie, Suresnes, France f Hospital Juan Canalejo 1, La Coru{\~n}a, Spain g CMX Research Inc. & University of Toronto, Toronto, Ontario, Canada h GlaxoSmithKline Clinical Development and Medical Affairs, Madrid, Spain i Department of Biostatistics, GlaxoSmithKline, Research Triangle Park, NC, USA ⁎ Corresponding author. The belonging to this abstract is placed below. Table 1 ",

year = "2009",

month = apr,

doi = "10.1016/j.eururo.2008.06.035",

language = "English (US)",

volume = "55",

pages = "1000--1001",

journal = "European urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "4",

}

TY - JOUR

T1 - Corrigendum to

T2 - "The Influence of Baseline Parameters on Changes in IPSS with Dutasteride, Tamsulosin, and Combination Therapy: Two-Year Data from the Combination of Avodart® and Tamsulosin (CombAT) Study" [Eur Urol Suppl 2008;7:171 (Abstract no. 403)] (DOI:10.1016/S1569-9056(08)60399-1)

AU - Roehrborn, Claus

AU - Tubaro, Andrea

AU - Montorsi, Francesco

AU - Maffezzini, Massimo

AU - Lebret, Thierry

AU - Chantada, Venancio

AU - Barkin, Jack

AU - Castro, Ramiro

AU - Wilson, Tim

N1 - Funding Information: ® and Tamsulosin (CombAT) Study” [Eur Urol Suppl 2008;7:171 (Abstract no. 403)] Claus G. Roehrborn a ⁎ claus.roehrborn@utsouthwestern.edu Andrea Tubaro b Francesco Montorsi c Massimo Maffezzini d Thierry Lebret e Venancio Chantada f Jack Barkin g Ramiro Castro h Tim Wilson i a Department of Urology, UT Southwestern Medical Center, Dallas, Texas, USA b 2nd School of Medicine, La Sapienza University, Rome, Italy c Department of Urology, Universita Vita Salute San Raffaele, Milan, Italy d Department of Urology, Galliera Hospital, Genova, Italy e CMC Foch, Service d’Urologie, Suresnes, France f Hospital Juan Canalejo 1, La Coruña, Spain g CMX Research Inc. & University of Toronto, Toronto, Ontario, Canada h GlaxoSmithKline Clinical Development and Medical Affairs, Madrid, Spain i Department of Biostatistics, GlaxoSmithKline, Research Triangle Park, NC, USA ⁎ Corresponding author. The belonging to this abstract is placed below. Table 1

PY - 2009/4

Y1 - 2009/4

UR - http://www.scopus.com/inward/record.url?scp=60249102857&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60249102857&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2008.06.035

DO - 10.1016/j.eururo.2008.06.035

M3 - Comment/debate

C2 - 28011054

AN - SCOPUS:60249102857

SN - 0302-2838

VL - 55

SP - 1000

EP - 1001

JO - European urology

JF - European urology

IS - 4

ER -

Corrigendum to: "The Influence of Baseline Parameters on Changes in IPSS with Dutasteride, Tamsulosin, and Combination Therapy: Two-Year Data from the Combination of Avodart® and Tamsulosin (CombAT) Study" [Eur Urol Suppl 2008;7:171 (Abstract no. 403)] (DOI:10.1016/S1569-9056(08)60399-1)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this

Corrigendum to: "The Influence of Baseline Parameters on Changes in IPSS with Dutasteride, Tamsulosin, and Combination Therapy: Two-Year Data from the Combination of Avodart^® and Tamsulosin (CombAT) Study" [Eur Urol Suppl 2008;7:171 (Abstract no. 403)] (DOI:10.1016/S1569-9056(08)60399-1)